Recent Advances in Multiple Myeloma: Highlights from the IMS 2022 Meeting and Beyond - Episode 8

Transplant-Ineligible Multiple Myeloma: The ENDURANCE Study

, , , ,

Andrew Cowan, MD, presents the results of the ENDURANCE study comparing two triplet regimens in transplant-ineligible MM.